Prognosis

World’s First Covid Vaccine You Inhale Is Approved in China

CanSino’s shares rise as much as 14.5% after China approval
Needle-free delivery could appeal to vaccine-hesitant people

WATCH: Xuefeng Yu, chairman and CEO of Cansino Biologics Inc., discusses the company’s newest needle-free covid vaccine, the significance of it being administered this way and the challenges faced in developing the vaccine.Source: Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Kanoko Matsuyama

September 5, 2022 at 3:38 AM UTC

This article is for subscribers only.

China became the first country to approve a needle-free, inhaled version of a Covid-19 vaccine made by Tianjin-based CanSino Biologics Inc., pushing the company’s shares up as much as 14.5% Monday morning in Hong Kong.

China’s National Medical Products Administration approved CanSino’s Ad5-nCoV for emergency use as a booster vaccine, the company said in a statement to the Hong Kong Stock Exchange on Sunday.